The BreastDefense Story

View this video to learn more about BreastDefense

BreastDefense

image71

Molecular Measurements of Breast Cancer

BreastDefense is a molecular screening test that is aiming for 99% accuracy in the detection of  all major invasive breast cancers - at any stage from 1 through 4.

Put Fear at Bay with BreastDefense

About 1 woman in 8 in the U.S. will develop invasive breast cancer during her lifetime. It is estimated that 260,120 women in 2018 will be diagnosed.  Invasive breast cancers are dangerous.

Women need an accurate screen and survivors want to monitor themselves. BreastDefense, an easy and accurate blood test will put fear at bay. It will eliminate the need for inaccurate tests that can do more harm than good.

Interested in investing in BreastDefense?

Contact Peter Blaney at peterblaney@induranventures.com


SignPost has already raised $1.1M to complete the first development trial of BreastDefense.

Today Induran is raising additonal funds to complete validation studies.

We are 99% confident that the validation studies will succeed and BreastDefense can begin saving lives.  

To get more information on BreastDefense